市場調査レポート
商品コード
1099762
小児臨床試験の世界市場規模調査:フェーズ別、試験設計別、治療分野別、地域別予測(2022年~2028年)Global Pediatric Clinical Trials Market Size study, By Phase, By Study Design, By Therapeutic Area, and Regional Forecasts 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
小児臨床試験の世界市場規模調査:フェーズ別、試験設計別、治療分野別、地域別予測(2022年~2028年) |
出版日: 2022年06月22日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
小児における慢性疾患や感染症の増加、小児臨床試験に対する意識の高まり、小児臨床試験に対する最近の資金提供活動の増加は、小児臨床試験市場の成長を促進する要因となっています。
また、製薬企業による研究開発投資の増加も、市場成長の促進要因として作用すると予想されます。
当レポートでは、世界の小児臨床試験市場について調査分析し、市場力学、業界分析、市場分析、競合情報など、体系的な情報を提供しています。
List of figures
Global Pediatric Clinical Trials Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The Pediatric Clinical Trials refers to clinical trials that are designed and conducted specifically for children. Pediatric clinical trials are mainly conducted to study and treat different therapeutic areas in children such as respiratory diseases, infectious diseases, oncology, diabetes. The rising burden of chronic and infectious diseases in pediatric and increasing awareness towards pediatric clinical trials as well as recent funding activities towards pediatric clinical trials are factors that are accelerating the global market demand. For instance, according to American Academy of Pediatrics - as of 2020, around 10 million children and adolescents in the United States are affected by some form of chronic illness or disability. Furthermore, as per World Health Organization (WHO) estimates - as of 2021, every year around 400 000 children and adolescents of 0-19 years affected by cancer. The most prevalent types of childhood cancers include leukemias, brain cancers, lymphomas and solid tumours, such as neuroblastoma and Wilms tumours. Moreover, in high-income countries, more than 80% of children with cancer are cured. Whereas, in low- and middle-income countries (LMICs), only less than 30% are cured. However, recent funding activities from regulatory organizations are likely to influence the growth of pediatric clinical trials. For instance, in May 2022, Australian Government's Medical Research Future Fund (MRFF) awarded grant of USD 11 million to Five University of Sydney researchers. This funding intended to improve clinical and health outcomes of children affected with juvenile idiopathic arthritis. Also, growing research & development investments by pharmaceutical players and increasing adoption contract research organizations are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, stringent government regulations and cumbersome approval processes impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Pediatric Clinical Trials Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing healthcare spending and presence of leading market players. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as growing pediatric population and surging penetration of Clinical research organization (CROs) in the region, would create lucrative growth prospects for the global Pediatric Clinical Trials Market across the Asia Pacific region.
Major market players included in this report are:
ICON plc
Syneos Health
Medpace, Inc.
PPD Inc.
Premier Research
LabCorp Drug Development
QPS Holdings.
Pfizer Inc.
The Emmes Company, LLC
IQVIA Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Phase
Phase I
Phase II
Phase III
Phase IV
By Study Design
Treatment Studies
Observational Studies
By Therapeutic Area
Respiratory Diseases
Infectious Diseases
Oncology
Diabetes
Other Therapeutic Areas
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Pediatric Clinical Trials Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors